[
  {
    "topic_or_construct": "cannabis use and psychotic-like experiences",
    "measured_by": "Structured interviews and self-report questionnaires",
    "justification": "The paper discusses systematic reviews that used structured interviews and self-report questionnaires to assess the association between cannabis use and psychotic-like experiences in healthy populations. The association is analyzed using effect sizes ranging from OR 1.75 to OR 2.59."
  },
  {
    "topic_or_construct": "psychometric schizotypy",
    "measured_by": "Schizotypal Personality Questionnaire (SPQ), Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)",
    "justification": "Szoke and colleagues (2014) conducted a meta-analysis using measures like the Schizotypal Personality Questionnaire (SPQ) and Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE) to study the link between cannabis use and psychometric schizotypy. The study found significant associations across all schizotypy dimensions."
  },
  {
    "topic_or_construct": "development of psychosis",
    "measured_by": "Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria and International Classification of Diseases (ICD)",
    "justification": "The association between cannabis use and the risk of developing psychosis was studied using diagnostic criteria from DSM and ICD. Reviews like Marconi et al. (2016) reported odds ratios for various levels of cannabis use in relation to psychosis development."
  },
  {
    "topic_or_construct": "psychotic symptom severity in psychosis patients",
    "measured_by": "Positive and Negative Syndrome Scale (PANSS)",
    "justification": "Studies summarized in the reviews of Schoeler et al. (2016) and Sabe et al. (2020) used the Positive and Negative Syndrome Scale (PANSS) to measure psychotic symptom severity among patients with established psychotic disorders. These studies found varied associations based on cannabis use patterns."
  },
  {
    "topic_or_construct": "relapse in psychosis population",
    "measured_by": "Rehospitalization records and clinical follow-up scales",
    "justification": "Zammit et al. (2002) and Schoeler et al. (2016) investigated the impact of cannabis use on relapse using rehospitalization records and clinical follow-up scales, revealing a higher relapse risk with continued cannabis use compared to discontinued or non-use."
  }
]